Avestar Capital’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-74,523
Closed -$1.86M 342
2022
Q1
$1.86M Buy
74,523
+10,558
+17% +$271K 0.3% 68
2021
Q4
$1.7M Sell
63,965
-11,362
-15% -$303K 0.21% 103
2021
Q3
$2.03M Buy
75,327
+16,553
+28% +$449K 0.26% 86
2021
Q2
$1.59M Buy
58,774
+4,728
+9% +$127K 0.21% 124
2021
Q1
$1.45M Buy
54,046
+7,063
+15% +$192K 0.32% 64
2020
Q4
$1.29M Buy
46,983
+2,346
+5% +$64K 0.36% 53
2020
Q3
$1.21M Buy
44,637
+4,354
+11% +$119K 0.4% 45
2020
Q2
$1.09M Buy
40,283
+6,035
+18% +$157K 0.48% 51
2020
Q1
$839K Buy
+34,248
New +$883K 0.46% 56

Other funds holding IBDS

Avestar Capital's IBDS Position: Q2 2022 in Review

Avestar Capital sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2022, closing a stake of 74,523 shares — an estimated $1.86M sold.

Avestar Capital first reported a position in IBDS in Q1 2020 and held it in 9 quarters. The position peaked at $2.03M in Q3 2021. 117 funds tracked by Wall St. Rank hold IBDS as of Q2 2022.

  • Avestar Capital reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2022 after selling out during the quarter.
  • Avestar Capital sold 74,523 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2022, an estimated $1.86M.
  • Avestar Capital first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2020 and held it in 9 quarters.
  • Avestar Capital's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $2.03M in Q3 2021.
  • 117 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2022.

Based on Avestar Capital's 13F filing for Q2 2022, filed 28 Jul 2022.